Quetiapine Tablet, Film Coated
Product Images NDC 71205-026

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Quetiapine (NDC 71205-026). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Quetiapine Fumarate Structural Formula (378c155e 34bc 4167 9fc3 A4b6a7465414 01)

FDA Label Image

Figure 1 (378c155e 34bc 4167 9fc3 A4b6a7465414 02)

FDA Label Image

Figure 2 (378c155e 34bc 4167 9fc3 A4b6a7465414 03)

FDA Label Image

71205-026-90 (Image 05)

71205-026-90 (Image 05)
Quetiapine 300mg tablets, NDC 71205-026-90, are produced in the Czech Republic by Teva Czech Industries. Each bottle contains 90 pale yellow, capsule-shaped, biconvex, film-coated, unscored tablets, debossed with "93" on one side and "8164" on the other. The medication should be stored at 20°-25°C (68°-77°F) and kept out of the reach of children. A medication guide should be dispensed with each prescription. The SN and lot numbers are provided, but the expiration date is not available. Packaged by Proficient Rx LP in Thousand Oaks, CA.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.